The fundamental role of epigenetic events in cancer

Keywords

Epigenetics, Biology, DNA methylation, Chromatin, Cancer epigenetics

References

• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerCliment Forner — 1999
• Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasiaSvetlana Stefanova Radoulska — 2001
• Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylasesAngela Taddei, Christèle Maison, Danièle Roche — 2001
• p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.Elizabeth E. Cameron, Stephen B. Baylin, James G. Herman — 1999
• Science and societyJohn Ziman — 1978
• Methylated DNA and MeCP2 recruit histone deacetylase to repress transcriptionPeter Lloyd Jones, Gert Jan C. Veenstra, Paul A. Wade — 1998
• DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication fociMichael R. Rountree, Kurtis E. Bachman, Stephen B. Baylin — 2000
• Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulationLaurie Jackson‐Grusby, Caroline Beard, Richard Possemato — 2001
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Reinhard Dammann, Chun Li, Jung‐Hoon Yoon — 2000
• Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domainAndrew J. Bannister, Philip Zegerman, Janet F. Partridge — 2001
• Cell division is required for de novo methylation of CpG islands in bladder cancer cells.Mihaela Velicescu, Daniel J. Weisenberger, Felicidad A. Gonzales — 2002
• DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promotersKeith D. Robertson, Slimane Ait‐Si‐Ali, Tomoki Yokochi — 2000
• CpG methylation is maintained in human cancer cells lacking DNMT1Ina Rhee, Kamwing Jair, Ray-Whay Chiu Yen — 2000
• A histone H3 methyltransferase controls DNA methylation in Neurospora crassaHisashi Tamaru, Eric U. Selker — 2001
• Inactivation of the apoptosis effector Apaf-1 in malignant melanomaMarı́a S. Soengas, Paola Capodieci, David Polsky — 2001
• DNA methyltransferase Dnmt1 associates with histone deacetylase activityFrançois Fuks, Wendy A. Burgers, Alexander Brehm — 2000
• Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development.Hidewaki Nakagawa, Gerard J. Nuovo, Emmanuel E. Zervos — 2001
• Reduced genomic 5-methylcytosine content in human colonic neoplasia.Andrew P. Feinberg, Charles W. Gehrke, Kenneth C. Kuo — 1988
• Cancer-epigenetics comes of ageP A Jones, Peter W. Laird — 1999
• Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylationPaul A. Wade, Anne Gégonne, Peter Lloyd Jones — 1999

Cited by

• Bio-COBRA: absolute quantification of DNA methylation in electrofluidics chips.Romulo Martin Brena, Christoph Plass — 2009
• Molecular mechanisms of bromate-induced renal toxicityXiaoling Zhang — 2011
• Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.Mang-Li Zhang, Sen Lu, Shu-Sen Zheng — 2008
• Genetic Alterations in Pheochromocytoma and ParagangliomaJenny Welander — 2015
• Isolation and bioinformatics analysis of differentially methylated genomic fragments in human gastric cancer.Aijun Liao, Qi Su, Xun Wang — 2008
• Monitoring methylation changes in cancer.Verena Beier, Cora Mund, Jörg D. Hoheisel — 2007
• Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia寿 上淵 — 2003
• In Search of an Early Warning System for Pancreatic CancerW.J. Poppelbaum, N.E. Wisaman — 2003
• Drug reactivates genes to inhibit cancer.Filomena Torrecilla Gómez — 2003
• Optofluidic Lasers and Their Bio-Sensing ApplicationsWon Suk Lee — 2013
• Genetics of neuroendocrine and carcinoid tumours.Juan Carlos Vitoria Cormenzana — 2003
• Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2α Expression during Progression of Breast Cancer正清 矢冨, 剛志 久田, 光克 宇津木 — 2004
• Ontogeny of a Demethylation Domain and Its Relationship to Activation of Tissue-Specific Transcription1田美子 平原, はるか 加藤, トシ子 月野 — 2004
• Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tractmohammed gherib — 2004
• CpG island methylator phenotype in cancerJosé Antonio Colmenero Guerra — 2004
• Identification of a three-gene expression signature of poor-prognosis breast carcinomaIgnacio Arroyo Martínez — 2004
• Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.Miguel Angel Catalá Gorgues — 2005
• Folate and its preventive potential in colorectal carcinogenesis. How strong is the biological and epidemiological evidence?Mustaque Ahamad, Arthur Bernstein — 2005
• Coordinated Changes in DNA Methylation and Histone Modifications Regulate Silencing/Derepression of Luteinizing Hormone Receptor Gene TranscriptionRobert E. Griffin — 2005
• Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1Kin‐Fai Chan, Iris L. K. Wong, Brendan A. Burkett — 2006

Related papers

• Epigenomics and epigenetic therapy of cancer.Robert Brown, Gordon Strathdee — 2002
• Epigenetics of colon cancer.Sharad Khare, Mukesh Verma — 2012
• Role of Epigenetic alterations in the development of cancersRiffat Mehboob — 2022
• Role of Epigenetic alterations in the development of cancersRiffat Mehboob — 2021
• DNA methylation as a regulatory mechanism for gene expression in mammals.Alan Šerman, Maja Vlahović, Ljiljana Šerman — 2006
• Epigenetic changes in cancerKirsten Grønbæk, Christoffer Hother, Peter A. Jones — 2007